Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and...

Global shipments of XR headwear declined 38.7% year-on-year to 1.9 million units in the first half of 2026, according to the latest data from Omdia. While XR glasses are gaining traction, their growth from a small base was insufficient to counter a steep drop in XR headset shipments. By 2025, the market had recorded...